Does RISANKIZUMAB-RZAA Cause Toe amputation? 35 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Toe amputation have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
35
Reports of Toe amputation with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
13
Hospitalizations
How Dangerous Is Toe amputation From RISANKIZUMAB-RZAA?
Of the 35 reports, 13 (37.1%) required hospitalization.
Is Toe amputation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Toe amputation?
CANAGLIFLOZIN (2,193)
CANAGLIFLOZIN\METFORMIN (196)
EMPAGLIFLOZIN (149)
INSULIN GLARGINE (133)
ADALIMUMAB (124)
METFORMIN (103)
BECAPLERMIN (102)
ETANERCEPT (100)
METHOTREXATE (84)
TOCILIZUMAB (66)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Toe amputation Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA